KENNIE MEDS Trademark

Trademark Overview


On Monday, May 12, 2025, a trademark application was filed for KENNIE MEDS with the United States Patent and Trademark Office. The USPTO has given the KENNIE MEDS trademark a serial number of 99179929. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Thursday, October 23, 2025. The KENNIE MEDS trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Pharmaceutical preparations, namely, ibuprofen tablets; acetaminophen tablets; bismuth subsalicylate tablets for pharmaceutical purposes; famotidine tablets; diphenhydramine tablets; guaifenesin tablets; loperamide tablets; hydrocortisone topical cream; fluticasone nasal spray; oxymetazoline nasal spray; saline nasal spray; liquid acetaminophen for children; liquid ibuprofen for children; liquid guaifenesin; azithromycin prescription tablets; ondansetron prescription tablets; cephalexin prescription tablets; hangover herbal supplement capsules; cold and flu herbal supplement capsules; scopolamine patches.

Calcium carbonate tablets.
kennie meds

General Information


Serial Number99179929
Word MarkKENNIE MEDS
Filing DateMonday, May 12, 2025
Status680 - APPROVED FOR PUBLICATION
Status DateThursday, October 23, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


NOT AVAILABLE"MEDS"
Goods and ServicesPharmaceutical preparations, namely, ibuprofen tablets; acetaminophen tablets; bismuth subsalicylate tablets for pharmaceutical purposes; famotidine tablets; diphenhydramine tablets; guaifenesin tablets; loperamide tablets; hydrocortisone topical cream; fluticasone nasal spray; oxymetazoline nasal spray; saline nasal spray; liquid acetaminophen for children; liquid ibuprofen for children; liquid guaifenesin; azithromycin prescription tablets; ondansetron prescription tablets; cephalexin prescription tablets; hangover herbal supplement capsules; cold and flu herbal supplement capsules; scopolamine patches.
Goods and ServicesCalcium carbonate tablets.

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, October 20, 2025
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 12, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressDenver, CO 80211

Trademark Events


Event DateEvent Description
Monday, May 12, 2025NEW APPLICATION ENTERED
Monday, May 12, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 12, 2025APPLICATION FILING RECEIPT MAILED
Thursday, September 25, 2025ASSIGNED TO EXAMINER
Thursday, September 25, 2025NON-FINAL ACTION WRITTEN
Thursday, September 25, 2025NON-FINAL ACTION E-MAILED
Thursday, September 25, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 20, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 20, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 20, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 23, 2025APPROVED FOR PUB - PRINCIPAL REGISTER